Hippo-YAP signaling pathway: A new paradigm for cancer therapy

Yanlei Ma1, Yongzhi Yang1, Feng Wang1

  • 1Department of GI Surgery, Shanghai Tenth People's Hospital Affiliated with Tongji University, Shanghai, People's Republic of China.

Insights

The Hippo signaling pathway regulates organ size and is implicated in cancer. Its dysregulation is observed in various cancers, making it a target for new cancer therapies.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Background:

  • The Hippo signaling pathway controls organ size in mammals and Drosophila.
  • It involves a kinase cascade from Mst1/2 to YAP and TAZ.
  • YAP/TAZ are oncogenes, while other Hippo pathway members are tumor suppressors.

Purpose of the Study:

  • To review recent advances in understanding Hippo signaling's role in tumorigenesis.
  • To identify potential therapeutic targets for cancer treatment.

Main Methods:

  • Literature review of studies on Hippo signaling and cancer.
  • Analysis of the Hippo pathway's function in tumorigenesis.

Main Results:

  • Hippo pathway dysregulation is linked to various cancers.
  • YAP/TAZ act as oncogenes, promoting tumor growth.
  • Other Hippo pathway components exhibit tumor-suppressive functions.

Conclusions:

  • The Hippo signaling pathway is a critical regulator in cancer development.
  • Targeting the Hippo pathway offers promising avenues for novel cancer therapies.

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

1.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K